Researchers developing quick, inexpensive test to assess ER+ breast cancers
(Case Western Reserve University) Researchers from Case Western Reserve University are teaming with industry and other academics to develop a quick and inexpensive test to predict which women with ER+ breast cancer need chemotherapy and which need only the more tolerable hormonal therapy. The National Cancer Institute has awarded the group $3.3 million to support the effort.
Source: EurekAlert! - Biology - Category: Biology Source Type: news
More News: Biology | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hormonal Therapy | Hormones | Women